This study evaluates the utility of expanded panel non-invasive prenatal testing (NIPT) in detecting confined placental mosaicism of rare autosomal trisomies among pregnancies with placentally-mediated complications, including fetal growth restriction and severe preeclampsia.
Study Type
OBSERVATIONAL
Enrollment
70
Maternal blood sampling
Post-delivery placental sampling
Post-delivery umbilical cord blood sampling
University of California, San Francisco
San Francisco, California, United States
Composite adverse pregnancy outcome
Time frame: Through study completion, an average of 2 years
Preterm birth < 34 weeks
Time frame: Through study completion, an average of 2 years
Neonatal intensive care unit admission
Time frame: Through study completion, an average of 2 years
Intrauterine fetal demise
Death of fetus prior to delivery
Time frame: Through study completion, an average of 2 years
Neonatal demise
Death of infant within 28 days of birth
Time frame: Through study completion, an average of 2 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.